Fujian Wanchen Biotechnology Co. Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 165.479 million compared to CNY 216.300 million a year ago. Operating loss was CNY 12.281 million compared to operating Income of CNY 51.137 million a year ago. Net loss was CNY 12.771 million compared to net income of CNY 50.737 million a year ago. Basic loss per share from continuing operations was CNY 0.08 compared to basic earnings per share from continuing operations of CNY 0.44 a year ago.